weeks before conducting rectal cancer surgery and be prepared to
delay further if there is good regression."
Professor Heald concluded: "My hope for the future of rectal cancer
management is that there will be the following progression: more
precise TME surgery; immediate and earlier screening; immediate
and earlier endoscopy; detailed MRI planning; eventual triumph
over leakage; and more advanced laparoscopic and robotic surgical
equipment. In addition when CRT treatment is given, re-assessment
is now essential because further delay before fixing the operation may
be beneficial. In some carefully selected cases surgery may even be
radiotherapy followed by neo-adjuvant chemotherapy in locally
advanced rectal cancer the RAPIDO Trial. BMC Cancer 2013; 13:
279. doi: 10.1186/1471-2407-13-279
TME Development Programme and is highly involved in the Champalimaud Centre for the Unknown in Lisbon, Portugal.
For the past 20 years his main interest has been the research and development of the total mesorectal excision (TME)
technique for rectal cancer.
He is a former Vice-President of the Council at the Royal College of Surgeons of England and is past-President of the
Section of Coloproctology. He has received honorary degrees and/ or professorships from a number of countries including
Sweden, Austria, Switzerland, US and China.